Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on BreastVAX combines radiation boost with immune checkpoint blockade therapy in breast cancer, currently in Phase 1/Phase 2 and not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING